UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000005872
Receipt No. R000006905
Scientific Title A Phase 2 Study of Carboplatin, Pemetrexed, and Bevacizumab followed by Bevacizumab and Erlotinib maintenance for Non-squamous Non-Small Cell Lung Cancer not harboring EGFR mutations. (HOT1101)
Date of disclosure of the study information 2011/06/28
Last modified on 2017/01/04 13:10:34

No. Disposal Last modified on Item of update
1 Insert 2011/06/28 22:06:19
2 Update 2013/12/28 14:48:14 TEL
Email
Email
3 Update 2017/01/04 13:07:59 Control
4 Update 2017/01/04 13:09:24 Name of primary sponsor
Organization
Organization
Division
5 Update 2017/01/04 13:10:34 Recruitment status
Date of protocol fixation
Publication of results


Contact us.